Karyopharm Therapeutics (KPTI) Receivables - Net (2019 - 2026)
Karyopharm Therapeutics' Receivables - Net was $29.87 million in Q2 2026, down 9.3% from $32.93 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Karyopharm Therapeutics came in at $26.18 million, down 14.9% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $30.77 million in FY2024 (+14.1%), $26.96 million in FY2023 (-42.7%), $47.09 million in FY2022 (+109.3%) and $22.5 million in FY2021 (+74.4%).
- Quarterly Receivables - Net has moved between $18.75 million (Q3 2021) and $47.09 million (Q4 2022) over five years.
- Compared with a year earlier, Receivables - Net was higher in three of the last seven quarters, with an average decline of 3.7%.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2022 (growth of 109.3%); the worst was Q4 2023 (a decline of 42.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 14.45 Mn | -211.97 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.87 Mn |
| Dec 31, 2025 | 26.18 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | 32.93 Mn |
| Mar 31, 2025 | 35.24 Mn |
| Dec 31, 2024 | 30.77 Mn |
| Sep 30, 2024 | 31.78 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 31.08 Mn |
| Dec 31, 2023 | 26.96 Mn |
| Sep 30, 2023 | 37.92 Mn |
| Jun 30, 2023 | 32.28 Mn |
| Mar 31, 2023 | 35.20 Mn |
| Dec 31, 2022 | 47.09 Mn |
| Sep 30, 2022 | 27.45 Mn |
| Jun 30, 2022 | 23.48 Mn |
| Mar 31, 2022 | 24.99 Mn |
| Dec 31, 2021 | 22.50 Mn |
| Sep 30, 2021 | 18.75 Mn |
| Jun 30, 2021 | 17.89 Mn |
API Access
Karyopharm Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();